Discover 2,380 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,380
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
for
Pulmonary Arterial Hypertension
Location: Chicago IL, St Louis MO, Ann Arbor MI, Cincinnati OH,
Sponsor: Gossamer Bio USA, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06274801
Phase 3, Recruiting
Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
for
Diabetic Retinopathy (DR)
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT07296952
Recruiting
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Chicago IL, Ann Arbor MI, Cincinnati OH, Pittsburgh PA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
for
Sickle Cell Disease
Location: Chicago IL, Kansas City MO, Travelers Rest SC, Greer SC,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT05431088
Phase 2, Phase 3, Recruiting
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
for
Sickle Cell Disease
Location: Chicago IL, Indianapolis IN, Cincinnati OH,
Sponsor: Disc Medicine, Inc
Sex: All
Age: 18+
Code: NCT07187973
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Chicago IL, Arlington Heights IL, Detroit MI,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
UIC Multi-Ethnic DCM Registry
for
Heart Failure, Dilated Cardiomyopathy (DCM)
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT07145138
Recruiting
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
for
End Stage Renal Disease on Dialysis
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT07014111
Recruiting
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
for
Lung Neoplasm Malignant
Location: Chicago IL, Clermont FL, Portland OR
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07286149
Phase 1, Phase 2, Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
for
Multiple Myeloma
Location: Chicago IL, Milwaukee WI, Madison WI, Green Bay WI,
Sponsor: European Myeloma Network B.V.
Sex: All
Age: 18+
Code: NCT05243797
Phase 3, Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
for
Community-acquired Pneumonia, Influenza, COVID-19
Location: Chicago IL, Ann Arbor MI, Columbus OH, Kitchener,
Sponsor: UMC Utrecht
Sex: All
Age: 18+
Code: NCT02735707
Phase 3, Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Chicago IL, Grand Rapids MI, St Louis MO, Detroit MI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06827236
Phase 1, Phase 2, Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging